Written Question·Department of Health and Social Care·UIN 109128
Prostate Cancer: Medical Treatments
Tabled: 28 January 2026
Answered: 3 February 2026
Question
Wendy Morton
Conservative — Aldridge-Brownhills
To ask the Secretary of State for Health and Social Care, with reference to HCWS1248, what assessment has been made of existing regional variation in access to prostate cancer treatments and what steps are being taken to prevent disparities in uptake betw
Answer
Dr Zubir AhmedApproximately 2,000 men diagnosed in the last three months with non‑metastatic prostate cancer will now be able to receive abiraterone where it is of clinical benefit, alongside prednisolone. An additional 7,000 men are expected to be diagnosed with prost...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 109128) →